Baker Bros. Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Baker Bros. Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-202,630	Closed	-$18.6M	–	136
2015 Q3	$18.6M	Hold	202,630	–	–	0.17%	45
2015 Q2	$17.8M	Hold	202,630	–	–	0.16%	50
2015 Q1	$15M	Hold	202,630	–	–	0.13%	51
2014 Q4	$11.3M	Buy	+202,630	New	+$10.6M	0.12%	46
2014 Q3	–	Sell	-793,221	Closed	-$32.8M	–	110
2014 Q2	$32.8M	Buy	793,221 +263,231	+50%	+$13.6M	0.4%	30
2014 Q1	$36.7M	Sell	529,990 -748	-0.1%	-$54.9K	0.47%	32
2013 Q4	$32M	Buy	530,738 +228,994	+76%	+$12.5M	0.45%	29
2013 Q3	$18.3M	Sell	301,744 -223,369	-43%	-$15.8M	0.26%	34
2013 Q2	$35.2M	Buy	+525,113	New	+$23.6M	0.7%	22

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baker Bros. Advisors's CLVS Position: Q4 2015 in Review

Baker Bros. Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q4 2015, closing a stake of 202,630 shares — an estimated $18.6M sold.

Baker Bros. Advisors first reported a position in CLVS in Q2 2013 and held it in 9 quarters. The position peaked at $36.7M in Q1 2014. 157 funds tracked by Wall St. Rank hold CLVS as of Q4 2015.

Baker Bros. Advisors reported no remaining Clovis Oncology, Inc. position as of Q4 2015 after selling out during the quarter.
Baker Bros. Advisors sold 202,630 Clovis Oncology, Inc. shares in Q4 2015, an estimated $18.6M.
Baker Bros. Advisors first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 9 quarters.
Baker Bros. Advisors's Clovis Oncology, Inc. position peaked at $36.7M in Q1 2014.
157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2015.

Based on Baker Bros. Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.